Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR+108.3%
5Y CAGR+35.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+108.3%/yr
Annual compound
5Y CAGR
+35.8%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 839.36% |
| 2024 | -76.40% |
| 2023 | -58.95% |
| 2022 | 92.92% |
| 2021 | 1679.33% |
| 2020 | 181.57% |
| 2019 | 0.00% |